Adequacy of examining one sputum specimen in tuberculosis drug resistance surveys

by Subramanyam Balaji, Vanaja Kumar, Prabu Seenivasan, R Radhakrishnan, Gomathi Sekar, Thiruvengadam Kannan, Vedhachalam Chandrasekaran, Soumya Swaminathan, Nagamiah Selvakumar
Published 2016-01-01

Randomized clinical trial of thrice-weekly 4-month moxifloxacin or gatifloxacin containing regimens in the treatment of new sputum positive pulmonary tuberculosis patients.

by Mohideen S Jawahar, Vaithilingam V Banurekha, Chinnampedu N Paramasivan, Fathima Rahman, Rajeswari Ramachandran, Perumal Venkatesan, Rani Balasubramanian, Nagamiah Selvakumar, Chinnaiyan Ponnuraja, Allaudeen S Iliayas, Navaneethapandian P Gangadevi, Balambal Raman, Dhanaraj Baskaran, Santhanakrishnan R Kumar, Marimuthu M Kumar, Victor Mohan, Sudha Ganapathy, Vanaja Kumar, Geetha Shanmugam, Niruparani Charles, Murugesan R Sakthivel, Kannivelu Jagannath, Chockalingam Chandrasekar, Ramavaram T Parthasarathy, Paranji R Narayanan
Published 2013-01-01